Search for: "Michael Lilly"
Results 61 - 80
of 251
Sorted by Relevance
|
Sort by Date
9 Dec 2009, 3:59 pm
: Roche v Cipla (Spicy IP) India, intellectual property and biotechnology industry – to protect, or not to protect (Biotech Blog) Italy: SPCs, competition and refusal to supply – Italian Competition Authority’s responses to ‘refusal to deal’ questionnaire (The SPC Blog) US: Ariad v Lilly – amicus briefs by Regents of University of California et al and various companies (Patent Docs) (Patent Docs) US: Ariad v Lilly – A look back at the… [read post]
25 Feb 2015, 8:03 am
Panel Four: Patent Prosecution of Biologics Ken Gandy, Woodard, Emhardt, Moriarty, McNett & Henry Professor Nicholson Price, University of New Hampshire School of Law Jay Sanders, Faegre Baker Daniels Moderator: Michael Bartol, Bose McKinney & Evans 4:15 p.m. - 5:30 p.m. [read post]
25 Feb 2015, 8:49 am
Panel Four: Patent Prosecution of Biologics Ken Gandy, Woodard, Emhardt, Moriarty, McNett & Henry Professor Nicholson Price, University of New Hampshire School of Law Jay Sanders, Faegre Baker Daniels Moderator: Michael Bartol, Bose McKinney & Evans 4:15 p.m. - 5:30 p.m. [read post]
4 Aug 2010, 12:21 am
(Patent Docs) Gemzar (Gemcitabine) – US: CAFC affirms invalidity of Lilly’s Gemzar patent for obviousness-type double patenting: Sun Pharmaceuticals v. [read post]
2 Jun 2015, 5:46 am
The post Why Canadians Have Good Reason to Be Wary of the TPP appeared first on Michael Geist. [read post]
3 Apr 2009, 4:24 am
In Hawaii Reporter -Hawai`i's Environmental Protection Act requires an Environmental Impact Statement (EIS) for major government actions that may have a significant effect on the environment. [read post]
4 Jun 2008, 10:51 am
In an IPFrontline post titled Keys to 111th Congress Patent Reform, Harold Wegner writes:If judged by the current Congressional stalemate, an apparently complete lack of understanding exists within bio/pharma/chemistry as to the needs of essentially all other mainstream industries where litigation costs (in red) far outweigh patent profits (in blue) as explained by Professors James Bessen and Michael J. [read post]
29 Sep 2015, 9:46 am
The post The TPP End Game and the Canadian Election appeared first on Michael Geist. [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
20 Feb 2015, 10:54 am
MICHAEL D. [read post]
1 Jun 2017, 9:45 am
WATER LAW Kidd, Michael, Water and the Law: Towards Sustainability (2014). [read post]
14 Jul 2012, 6:46 am
Lilly Hon. [read post]
22 Dec 2015, 6:09 am
” by Alan Greenblatt for Governing Pennsylvania: “Scandal’s Web Trips Pennsylvania Attorney General Kathleen Kane” by Michael Wines for New York Times Elections “Sanders Data Controversy Spotlights Powerful Gatekeeper” by Nancy Scola for Politico “Lindsey Graham Suspends His Presidential Campaign” by David Weigel and Robert Costa for Washington Post California: “When Legislator Resigns, Costs Can Be High to Voters, Party” by Laurel… [read post]
26 Dec 2023, 7:23 pm
“We don’t really know how many books it is,” says Michael Adams, a lexicographer and chair of the English department at Indiana University Bloomington. [read post]
20 Feb 2015, 10:54 am
MICHAEL D. [read post]
4 Dec 2014, 9:05 pm
If more editors handled situations this way, readers would think better of the press: Annalee Newitz of io9 offers “apology and analysis” for running tendentious, ill-reported article attacking animal-based research; Success of personal injury litigation is reshaping nursing home business in some states [WSJ] “With the Advent of Mandatory Paid Sick Leave in California, Here are a Few Sick Leave Excuses” [Coyote, related Massachusetts] Really, it’s not a… [read post]
26 Oct 2011, 7:59 am
Zyprexa, you may know, has serious side-effects that can lead to diabetes and its manufacturer, Eli Lilly, has been sued by tens of thousands of ill Zyprexa users, telling salespeople to downplay these side effects. [read post]
22 Sep 2009, 12:41 pm
Apologies to Michael Masnick. [read post]
8 Mar 2016, 6:02 am
, Day 24: Missing Balance on IP Border Measures, Day 25: The Treaties With the Treaty, Day 26: Why It Limits Canadian Cultural Policies, Day 27: Source Code Disclosure Confusion, Day 28: Privacy Risks from Source Code Rules, Day 29: Cultural Policy Innovation Uncertainty, Day 30: Losing Our Way on Geographical Indications, Day 31: Canadian Trademark Law Overhaul, Day 32: Illusory Safeguards Against Encryption Backdoors, Day 33: Setting the Rules for a Future Pharmacare Program, Day 34: PMO Was… [read post]
